Invention Grant
- Patent Title: Clinical laboratory-based disease management program, with automated patient-specific treatment advice
-
Application No.: US16403915Application Date: 2019-05-06
-
Publication No.: US11195603B2Publication Date: 2021-12-07
- Inventor: Fredric L. Coe , Brian J. Coe , John R. Asplin , Enno de Vries , Elaine Worcester
- Applicant: Laboratory Corporation of America Holdings
- Applicant Address: US NC Burlington
- Assignee: Laboratory Corporation of America Holdings
- Current Assignee: Laboratory Corporation of America Holdings
- Current Assignee Address: US NC Burlington
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: G16H40/20
- IPC: G16H40/20 ; G06Q10/06 ; G16H15/00 ; G16H10/20 ; G16H70/20 ; G16H50/20 ; G16H10/40

Abstract:
A method is provided, the method including receiving a test result data, wherein said test result data represents a result of a test on a physical specimen, associating said test result data with a standard-of-care data, wherein said standard-of-care data represents a recommended course of action for the condition represented by the test result data, and transforming said specimen data and said standard-of-care data into a human-readable form. A system including a processor is provided, a software adapted to be executed on said processor, said software comprising instructions for receiving a test result data, wherein said test result data represents a result of a test on a physical specimen, associating said test result data with a standard-of-care data, wherein said standard-of-care data represents a recommended course of action for the condition represented by the test result data, and transforming said specimen data and said standard-of-care data into a human-readable form.
Public/Granted literature
- US20200043584A1 Clinical Laboratory-Based Disease Management Program, With Automated Patient-Specific Treatment Advice Public/Granted day:2020-02-06
Information query